GLP-1 therapies, or glucagon-like peptide-1 receptor agonists , represent a substantial development in how we treat type 2 diabetes . These new therapies work by mimicking the body’s inherent GLP-1 hormone https://bookmarkspring.com/story16930370/glp-1-a-revolutionary-breakthrough-in-glucose-treatment